PEETZ CHRISTOPHER (President and CEO) sold 9.3% of their position (20K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.45M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$2.94
Trade value
$58.72K
% of position
Common Stock
Shares
−12.13K
Price / share
$121.65
Trade value
$1.48M
% of position
Common Stock
Shares
−4.18K
Price / share
$122.34
Trade value
$511.50K
% of position
Common Stock
Shares
−1.98K
Price / share
$123.74
Trade value
$244.39K
% of position
Common Stock
Shares
−1.71K
Price / share
$124.79
Trade value
$213.39K
% of position
Net shares
+0.00
Net value
-$2.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | M · Option Exercise | +20K | $2.94 | $58.72K | 10.3% | 194.31K | 214.31K |
| Common Stock Direct | 7/6/2026 | S · Sale | −12.13K | $121.65 | $1.48M | 5.7% | 214.31K | 202.18K |
| Common Stock Direct | 7/6/2026 | S · Sale | −4.18K | $122.34 | $511.50K | 2.1% | 202.18K | 197.99K |
| Common Stock Direct | 7/6/2026 | S · Sale | −1.98K | $123.74 | $244.39K | 1.0% | 197.99K | 196.02K |
| Common Stock Direct | 7/6/2026 | S · Sale | −1.71K | $124.79 | $213.39K | 0.9% | 196.02K | 194.31K |
| Total | +0.00 | -$2.39M | ||||||
Employee Stock Option (right to buy)
Common Stock
20K shares
Shares
−20K
Strike price
2.936
Held after
108.49K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock20K shares | 7/6/2026 | M · Option Exercise | −20K | 2.936 | — | 108.49K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 187.50K | Indirect |
| Total | 187.50K | 187.50K indirect |